Skip to content

Cineverse Corp. CNVS Exercise Of Common Stock Warrant

Exercise Of Common Stock Warrant at other companies

Scilex Holding Company logo
Scilex Holding CompanySCLX
$2.56M
Envoy Medical logo
Envoy MedicalCOCH
$2.95M+114%
AvePoint, Inc. logo
AvePoint, Inc.AVPT
$0-100%
OS Therapies logo
OS TherapiesOSTX
$722.22K
KULR Technology Group logo
KULR Technology GroupKULR
-$4.5
Immunome logo
ImmunomeIMNM
$0

Other financials

Income statement

See full
Revenue$26.0M+66.7%
Gross profit$13.8M
Operating income-$5.4M-353%
Net income-$875.0K-112%
EPS (diluted)-$0.05-115%

Balance sheet

See full
Cash & equivalents$3.4M-75.7%
Total debt$403.0K-12.8%
Total equity$44.3M+14.4%
Total assets$130.3M+79.7%

Cash flow

See full
Operating cash flow-$3.2M-126%
CapEx$267.3K-68.3%
Free cash flow-$2.9M-67.8%

Valuation

See full
Market cap$69.55M+3.4%
Enterprise value$66.56M+1.3%
P/S1.1×+0.2×

Profitability

See full
Gross margin98.5%
Operating margin-23.1%-33.2pp
Net margin-16.4%+0.2pp
FCF margin-23.7%+36.2pp

Returns & leverage

See full
Return on equity-23.9%-3.4pp
Debt / equity0.0×
Current ratio0.8×-0.3×

Where this comes from

Reported directly by Cineverse Corp. in its filing.

Tagged under the XBRL concept cnvs:ExerciseOfCommonStockWarrant.

The official record: Cineverse Corp.’s 10-K, filed June 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cineverse Corp.'s exercise of common stock warrant.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cineverse Corp.'s exercise of common stock warrant?
Cineverse Corp. (CNVS) reported exercise of common stock warrant of $1.46M in Q1 2026.
What does exercise of common stock warrant mean?
The cash proceeds received by the company from the exercise of outstanding warrants by holders to purchase common stock. This indicates a source of equity financing and the potential dilution impact on existing shareholders.